Skip to content
Why
How
What
Who
More
Why
How
What
Who
More
Category:
News Coverage
The Pharma Letter Podcast — Episode 33 — Why Boehringer and GSK are betting on Ochre
Ochre Bio, addressing the complexities of liver disease
Podcast: Ochre Bio’s Approach To Precision Medicine In Liver Treatment
Changing the Odds in Liver Disease with Computational Biology and Human-first Models
Top 10 Spatial Biology Companies of 2024
BBC Click
Leading innovation: 10 promising European startups focusing on biopharmaceuticals
How to make your organs last longer | Quin Wills | TEDxNoVA
Drug discovery: 20 startups to watch
GSK signs AI pact with Ochre to pinpoint source of liver diseases
←
Previous
Next
→
Join our Mailing List
Home
News
Careers
Contact Us
Login
Facebook-f
Twitter